Janus Henderson Biotech Innovation Fund II Ltd — Form D/A
Janus Henderson Biotech Innovation Fund II Ltd of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2025-08-18. $402.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-08-18
- Form: D/A
- Accession: 0002034032-25-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $402.0M
- Minimum investment: $100K
- Investors: 4
- Date of first sale: 2024-08-01
- Security types: equity, fund interests
- SEC file number: 021-521667
Issuer
- Name: Janus Henderson Biotech Innovation Fund II Ltd
- CIK: 0002034032
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2024
- Address: MAPLES CORPORATE SERVICES LIMITED, GRAND CAYMAN, E9, KY1-1104
- Phone: 345-949-8066
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Matteo Candolfini | Director | Grand Cayman, E9 |
| Toby Hiscock | Director | Grand Cayman, E9 |
| Kenneth MB Lubbock | Director | Grand Cayman, E9 |
| Hugh Ward | Director | Grand Cayman, E9 |
| N/A Janus Henderson Investors US LLC | Promoter | Denver, CO |
Other filings by this issuer (1)
More